Abstract
Background and Purpose: Thromboxane A2 (TXA2) receptors (TP) interact with the ligand TXA2 to induce platelet aggregation and regulate hemostasis. Recently TP-mediated signaling has been suggested to function in multiple cell types in the brain. In this report, we aim to study the expression and physiological role of TP in microglia, in particular after brain ischemia.Methods: Ischemic brain sections were analyzed for TP expression. Microglial cell line and primary microglia were cultured, or neuronal cell line co-culture system was used to determine the TP mediated signaling in inflammation and microglia activation.Results: We found that the TP level was significantly increased in ipsilateral mouse brain tissue at 24 h after ischemia-reperfusion, which was also found to partly co-localize with CD11b, a marker for microglial and infiltrated monocyte/macrophage, in peri-infarct area. Immunofluorescence staining of primary microglia and microglial cell line BV2 revealed the predominant membrane distribution of TP. Conditioned culture media from TP agonist U46619-treated BV2 cells decreased neuronal SH-SY5Y cell viability and induced apoptotic morphological changes. Furthermore, U46619 enhanced IL-1β, IL-6, and iNOS mRNA expression as well as IL-1β and NO releases in BV2 cells or primary microglia. Such stimulation could be attenuated by TP antagonist SQ29548 or MEK inhibitor U0126. The dose- and time-dependent extracellular-signal-regulated kinase (ERK) phosphorylation induced by U46619 further demonstrated ERK signaling-mediated microglia activation by TP agonist.Conclusion: This study has shown a novel role of TP in microglia activation via the ERK signaling pathway, which provides insights for the management of neuroinflammation in diseases like cerebral infarction.
Highlights
Cerebral infarction (CI), which accounts for 88% of all strokes, is an irreversible brain injury resulting from a disturbance in blood supply to cerebral tissue, characterized by high morbidity, disability, and mortality rate (Moskowitz et al, 2010)
To further determine the expression of TP in the brain, we performed TP immunofluorescence staining in the mouse brain sections and the result showed that the CD11b signal, a marker for microglial and infiltrated monocyte/macrophage (Akiyama and McGeer, 1990; Mazzone and Ricevuti, 1995), was remarkably up-regulated in the peri-infarct zone of ipsilateral hemisphere at 24 h after ischemia-reperfusion compared with that in contralateral hemisphere or the sham (Figure 1C)
In BV2 cells, similar staining pattern was observed, where TP was detected predominantly on the cytoplasmic membrane (Figure 2B). These results indicated that both primary microglia and BV2 cells expressed TP, which were primarily localized on the cytoplasmic membrane
Summary
Cerebral infarction (CI), which accounts for 88% of all strokes, is an irreversible brain injury resulting from a disturbance in blood supply to cerebral tissue, characterized by high morbidity, disability, and mortality rate (Moskowitz et al, 2010). Previous studies have shown that gene polymorphism of the TP is associated with CI (Kaneko et al, 2006; Zhao et al, 2013; Wang et al, 2014) Under pathological conditions, such as subarachnoid hemorrhage, the TP level is up-regulated in the brain (Ansar et al, 2010). U46619 enhanced IL-1β, IL-6, and iNOS mRNA expression as well as IL-1β and NO releases in BV2 cells or primary microglia. Such stimulation could be attenuated by TP antagonist SQ29548 or MEK inhibitor U0126. Conclusion: This study has shown a novel role of TP in microglia activation via the ERK signaling pathway, which provides insights for the management of neuroinflammation in diseases like cerebral infarction
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
